Issue 1/2003

Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study (1 — 7)

T., JIRASEK, P., HOZAK, V., MANDYS,

Molecular diagnosis of Epstein-Barr virus in paraffin-embedded tissues of tumors with abundant lymphoid infiltration (8 — 12)

, M., KORABECNA, M., LUDVIKOVA, A., SKALOVA

Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody (13 — 21)

A., CHRASTINA, S., PASTOREKOVA, J., PASTOREK

P53 and C-FOS overexpression in patients with thyroid cancer: an immunohistochemical study (26 — 30)

A., KATAKI, S., SOTORIANAKOS, N., MEMOS, M., KARAYIANNIS, E., MESSARIS, E., LEANDROS, A., MANOURAS, G., ANDROULAKIS,

Altered expression of p53 and MDM2 proteins in hematological malignancies (31 — 40)

E., KONIKOVA, J., KUSENDA,

Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer (41 — 46)

U., COSKUN, N., GUNEL, F.B., TORUNER, B., SANCAK, E., ONUK, O., BAYRAM, O., CENGIZ, E., YILMAZ, S., ELBEG, S., OZKAN,

Bronchial carcinoid tumors: long-term outcome after surgery (60 — 65)

P., FIALA, K., PETRASKOVA, S., CERNOHORSKY, Z., KINKOR, E., KREPELA, P., ZATLOUKAL,

Cavitated tumor as a clinical subentity in squamous cell lung cancer patients (66 — 73)

L.S., KOLODZIEJSKI, S., DYCZEK, K., DUDA, J., GORALCZYK, W.M., WYSOCKI, W., LOBAZIEWICZ,

Case-control study of multiple myeloma with special reference to diet as risk factor (79 — 83)

H., VLAJINAC, H.D., PEKMEZOVIC, B., ADANJA, J., MARINKOVIC, M.S., KANAZIR, N.D., SUVAJDZIC, N.D., COLOVIC,

Characterization of interleukin 10 and NO release by transpantable melanoma cell lines with regardto their progresion (85 — 90)

K., KOZLOWSKA, M., ZARECZNA, M., CICHOREK, S., WOJCIK,

Modulation of HLA class I expresion in multidrug-resistant human rhabdomyosarcoma cells (91 — 96)

C., MELGUIZO, J., PRADOS, J.A., MARCHAL, C., VELEZ, E., CARRILLO, H., BOULAIZ, I., SANCHEZ-MONTESINOS, R., MADEDDU, A., ARANEGA,

Expression of p65, DD3,an c-erbB2 genes in prostate cancer (97 — 101)

E., BALCZERCZAK, M., MIROWSKI, A., SASOR, R., WIERZBICKI,

Lipoxygenase inhibitors suppress proliferation of G5:113 fibrosarcoma cells in vitro but they have no anticancer activity in vivo (102 — 109)

Z., HOFEROVA, P., FEDOROCKO, M., HOFER, J., HOFMANOVA, A., KOZUBIK, V., ELIASOVA,

Comparision of the carcinogenic potential of streptozotocin by polarography and alkaline elution (110 — 116)

C., COJOCEL, L., NOVOTNY, A, VACHALKOVA, B., KNAUF,

Usefulness of technetium-99m methoxyisobutylisonitrile liver single photon emission computed tomography to detect hepatocellular carcinoma (117 — 119)

Y.J., HO, L.B, JEN, M.D., YANG, C.H., KAO, C.C., LIN, C.C., LEE,

Rapid HPLC analysis of melphalan applied to hypertermic isolation limb perfusion (120 — 124)

D., ROMANOVA, J., NETRIOVA, P., BOZEK, Z., OVESNA, K., KROUPA, E., VALOVICOVA, A, VACHALKOVA,

Immunocytochemical detection of p21ras, Raf-1, ERK1/MAP kinase and PKC isoforms in a 20-metylcholantrene-induced transformed murine embryonal fibroblast cells in culture (131 — 138)

K., BANERJEE, S.K., DAS, P., MUKHERJEE,

Correlation of poliferating cell nuclear antigen and bcl-2 expression with tumor front grading and metastasis in laryngeal squamous cell carcinoma (139 — 143)

C., BORAN, L., YILDIZ, B., KANDEMIR, F., KARAGOZ, S., BARIS, O., AYDIN,

Fine needle aspiration biopsy in a diagnostic workup algorithm of salivary gland tumors (144 — 147)

S., IVANOVA, J., SLOBODNIKOVA, E., JANSKA, J., JOZEFANKOVA,

Inhibition of adhesion breast cancer cells by anticoagulant drugs an cimetidine (148 — 151)

V., BOBEK, M., BOUBELIK, J., KOVARIK, O., TALTYNOV,

Conservative treatment for carcinoma of the anus - a report of 35 patients (152 — 158)

K., SERKIES, E., BEDNARUK-MLYNSKI, R., DZIADZIUSZKO, J., JASSEM,

Immunohistochemical detection of dipeptidyl peptidase IV (CD 26) in thyroid neoplasia using biotinylated tyramine amplification. (159 — 164)

I., KHOLOVA, M., LUDVIKOVA, A., RYSKA, J., CAP, L., PECEN, O., TOPOLCAN,

Establishment and cidofovir sensitivity of a cell line from a heart transplant recipient with multiple cutaneous tumors. (165 — 171)

M., SCHACKE, A., MEERBACH, R., THUST, P., HYCKEL, P., WUTZLER,

Efficacy and toxicity of low-dose melphalan in myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia. (172 — 175)

T., ROBAK, A., SZMIGIELSKA-KAPLON, H., URBANSKA-RYS, K., CHOJNOWSKI, A., WRZESIEN-KUS,

Administration of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) and diclofenac in the combination attenuates their anti-tumor activities. (176 — 184)

P., FEDOROCKO, Z., HOFEROVA, M., HOFER, P., BREZANI,

Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer. (185 — 190)

C., ATALAY, G., ATALAY, M., ALTINOK,

The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography. (191 — 197)

L., ELBL, H., HRSTKOVA, V., CHALOUPKA, J., NOVOTNY, J., MICHALEK,

Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers. (198 — 203)

B., PRZYBOJEWSKA, K., RYDZYNSKI, M., STEPNIK, M., JAKUBIAK, J., KOZAK, W., SZYMCZAK,

Weekly paclitaxel for advanced non-small cell lung cancer patients not suitable for platinum-based therapy. (204 — 209)

O., JUAN, A., ALBERT, T., VILLARROYA, R., SANCHEZ, R., CASAN, V., CARANANA, JM., CAMPOS, V., ALBEROLA,

Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer. (210 — 216)

U., COSKUN, N., GUNEL, E., ONUK, E., YILMAZ, O., BAYRAM, D., YAMAC, A., CIHAN, B., UCAN, Y., YILDIRIM, G., CELENKOGLU, S., OZKAN,

The value of 18F-fluorodeoxyglucose positron emission tomography with the additional help of tumor markers in cancer screening. (217 — 221)

YY., SHEN, C.T., SU, G.J., CHEN, Y.K., CHEN, A.C., LIAO, F.S., TSAI,

Comparing thallium-201 spect mammoscintigraphy and ultrasonography to detect breast cancer in mammographical dense breasts. (222 — 226)

D.R., CHEN, L.B., JENG, A., KAO, C.C., LIN, C.C., LEE,

Palliative treatment of cancer anorexia with oral suspension of megestrol acetate. (227 — 233)

M., TOMISKA, M., TOMISKOVA, F., SALAJKA, Z., ADAM, J., VORLICEK,

Fluid intake and bladder cancer. A case control study. (234 — 238)

V., RADOSAVLJEVIC, R., JANKOVIC, J., MARINKOVIC, M., DJOKIC,

NF-kB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer (239 — 245)

M.A. ALTINOZ, R. KORKMAZ

Detection of the most frequent mutations in BRCA1 gene on polyacrylamide gels containing Spreadex Polymer NAB. (246 — 250)

M., JANATOVA, M., POHLREICH, B., MATOUS,

High cell density-mediated pericellular hypoxia is a crucial factor inducing expression of the intrinsic hypoxia marker CA IX in vitro in HeLa cells. (251 — 256)

A., CHRASTINA,

Prevalence and prognostic value of c-erbB2 expression in non-small cell lung cancer (NSCLC). (257 — 261)

O., TURKEN, E., KUNTER, H., CERMIK, T., ISITMANGIL, G., KANDEMIR, M., YAYLACI, A., OZTURK,

Effect of tumor stage and nephrectomy on CD62P expression and sP-selectin concentration in renal cancer. (262 — 265)

M., MANTUR, H., KEMONA, R., KOZLOWSKI, I., KEMONA-CHETNIK,

Therapy increases poly-ADP-ribose and p53-Ser392-P levels in recurrent squamous cell lung cancer. (266 — 271)

L., CHYCZEWSKI, J.J., BRASZKO, , A., HOLOWNIA, R.M., MROZ, M., KOZLOWSKI, E., CHYCZEWSKA, J., LAUDANSKI

Androgen receptor in prostate carcinoma: immunohistochemical and ligand saturation analyses (287 — 290)

VAGUNDOVA, M., VAGUNDA, V., VERMOUSEK, I., & ROVNY, A

The free radical scavenging activity of four flavonoids determined by the comet assay (291 — 295)

K., HORVATHOVA, L., NOVOTNY, A, VACHALKOVA,

Clinical-scale selective depletion of alloreactive T cells using an anti-CD25 immunotoxin (296 — 299)

J., MICHALEK, RH., COLLINS, ES., VITETTA,

Ethanol fixation of lymphoma samples as an alternative approach for preservation of the nucleic acids (300 — 304)

J., SOUKUP, L., KRSKOVA, I., HILSKA, R., KODET,

Artemis, a novel guardian of the genome (311 — 318)

Z., DUDASOVA, M., CHOVANEC,

Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma. (319 — 325)

M., HERMANOVA, Z., LUKAS, I., KROUPOVA, Z., KLEIBL, J., NOVOTNY, R., NENUTIL, M., PAZOURKOVA, J., BRAZDIL, L., KREN, P., DITE,

Comparison of differential PCR and immunohistochemistry for the evaluation of c-erbB-2 in breast carcinoma and relationship to other prognostic factors (326 — 330)

S., ERDOGAN, M., ERGIN, I., TUNCER,

Binding analysis of HLA-G specific antibodies to hematopoietic cells isolated from leukemia patients (331 — 338)

K., POLAKOVA, E., BANDZUCHOVA, V., HOFMEISTER, EH., WEISS, H., HUTTER, G., RUSS,

The rate of apoptosis and expression of Bcl-2 and Bax in leukocytes of acute myeloblastic leukemia patients (339 — 344)

M., DABROWSKA, M., PIETRUCZUK, I., KOSTECKA, M., SUCHOWIERSKA, J., KLOCZKO, B., NASILOWSKA, U., BANY-LASZEWICZ, B., MARIANSKA,

Low antigen-dependent activity of T cells after repeated stimulation using dendritic cells and expansion with interleukin-2 (345 — 349)

T., BUCHLER, R., HAJEK, L., KOVAROVA, R., MUSILOVA, L., BOURKOVA, Z., CECH, P., VANOVA, E., TUZOVA, P., VIDLAKOVA, J., VORLICEK, M., PENKA,

Glutathione S-transferase M1 and P1 metabolic polymorphism and lung cancer predisposition (357 — 362)

E., RESZKA, W., WASOWICZ, K., RYDZYNSKI, N., SZESZENIA-DABROWSKA, W., SZYMCZAK,

Evaluation of dose homogenization and radiation carcinogenesis risk in total body irradiation for bone marrow transplantation (372 — 376)

K., OYSUL, B., DIRICAN, M., BEYZADEOGLU, S., SURENKOK, F., ARPACI, Y., PAK,

Cerebrospinal fluid and serum carcinoembryonic antigen in brain tumors (377 — 379)

B., GHOSH, SK., BATABYAL, S., SENGUPTA, SN., GHOSH, R., CHATTERJEE,

Effect of smoking and aging on micronucleus frequencies in human exfoliated buccal cells (380 — 382)

M., KONOPACKA,

Prognostic factors in the operative and palliative treatment of pancreatic cancer (383 — 387)

R., TALAR-WOJNAROWSKA, A., JANIAK, E., MALECKA-PANAS, , A., GASIOROWSKA, J., STRZELCZYK

Involvement of the nucleotide excision repair proteins in the removal of oxidative DNA base damage in mammalian cells (389 — 395)

I., RYBANSKA, M., PIRSEL,

The novel exon 11 mutation of BRCA1 gene in a high-risk family (403 — 407)

S., CIERNIKOVA, M., TOMKA, O., SEDLAKOVA, M., REINEROVA, V., STEVURKOVA, M., KOVAC, M., CENTE, D., ILENCIKOVA, V., BELLA, V., ZAJAC,

Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients (408 — 415)

M., KLOBUSICKA, J., KUSENDA, O., BABUSIKOVA,

Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype (416 — 421)

A., MLCAKOVA, O., BABUSIKOVA,

Leukemic cells and aberrant phenotypes in acute leukemia patients: a flow cytometry analysis (422 — 427)

D., VOSKOVA, L., VALEKOVA, J., FEDOROVA, J., HUDECEK, P., KUBISZ,

NMU-induced mammary carcinogenesis in female rats is influenced by repeated psychoemotional stress (428 — 432)

E., ADAMEKOVA, M., MARKOVA, P., KUBATKA, B., BOJKOVA, I., AHLERS, E., AHLERSOVA,

Fludarabine combined with cyclophosphamid is highly effective in the treatment of chronic lymphocytic leukemia (433 — 437)

E.TOTHOVA, A. KAFKOVA, M. FRICOVA, T. GUMAN, N. S TECOVA

The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST (438 — 442)

P., RUTKOWSKI, P., NYCKOWSKI, U., GRZESIAKOWSKA, ZI., NOWECKI, A., NASIEROWSKA-GUTTMEJER, A., PIENKOWSKI, K., DUDEK, M., KRAWCZYK, W., RUKA,

Effects of flavonoids on glutathione and glutathione-related enzymes in cisplatin-treated L1210 leukemia cells. (443 — 446)

L., CIPAK, E., BERCZELIOVA, H., PAULIKOVA,

Serum thrombopoietin levels in patients with reactive thrombocytosis due to lung cancer and in patients with essential thrombocythemia (447 — 451)

B., WERYNSKA, R., RAMLAU, M., PODOLAK-DAWIDZIAK, R., JANKOWSKA, I., PRAJS, L., USNARSKA-ZUBKIEWICZ, K., KULICZKOWSKI,

Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy (452 — 458)

I., OBLAK, P., STROJAN, B., ZAKOTNIK, L., SMID,